Humira(CF) 20 MG/0.2 ML syrings
Ended Awarded
- Contract number
- SPE2DB26FPVGE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,511
Award facts
- Contract value 100% obligated
- $1,510.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) 20 mg/0.2 ml prefilled syringes. The contract, issued on November 11, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company has demonstrated capability to meet federal procurement requirements through competitive awards, delivering a broad portfolio of pharmaceutical products ranging from specialty medications to vaccines and medical supplies. HUMIRA is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions within military healthcare populations. This individual delivery order exemplifies the operational flexibility of AmerisourceBergen's prime IDC vehicle, which enables rapid fulfillment of specific pharmaceutical requirements across the federal healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FPVGE?
SPE2DB26FPVGE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 11, 2025.
How much is contract SPE2DB26FPVGE worth?
The government has obligated $1,511 on SPE2DB26FPVGE.
Is contract SPE2DB26FPVGE an order under another contract?
Yes. SPE2DB26FPVGE is a delivery order under SPE2DB25D3003, an indefinite delivery contract.
Was contract SPE2DB26FPVGE competed?
The extent of competition for SPE2DB26FPVGE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award